The difference between AT III (AUC = 0.791, p = 0.002) and albumin (AUC = 0.839, p < 0.001) was not clear, indicating that AT III is not a novel biomarker that could be used to select patients with lymphoma from those with other diseases. The gene discussed is ALB; the disease is lymphoma.